Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

This Newly-Tested Tool Predicts PICC-DVT Risk

J Thromb Haemost; ePub 2017 Sep 13; Chopra, et al

A newly-tested tool can estimate the risk of deep vein thrombosis (DVT) in patients with peripherally inserted central catheters (PICCs), according to a study involving more than 23,000 individuals. Participants with upper extremity DVT were divided into 4 risk classes. The Michigan PICC-DVT Risk Score was then tested and validated to determine factors linked with PICC-DVT. Among the results:

  • 2% of patients developed PICC-DVT.
  • Risk factors included DVT history, multi-lumen PICC, active cancer, presence of another central venous catheter, and white blood cell count >12,000.
  • Thrombosis rates were 0.9% for class I, 1.6% for class II, 2.7% for class III, and 4.7% for class IV.
  • Predicted probabilities were 0.9%, 1.5%, 2.6%, and 4.5%, respectively.
  • Patients in class II were 50% more likely to develop PICC-DVT than those in class I.
  • Patients in classes III and IV were nearly 3 and >5 times more likely, respectively.

Citation:

Chopra V, Kaatz S, Conlon A, et al. The Michigan Risk Score to predict peripherally inserted central catheter-associated thrombosis. [Published online ahead of print September 13, 2017]. J Thromb Haemost. doi:10.1111/jth.13794.

This Week's Must Reads

Higher AML, MDS risk linked to autotransplants, Radivoyevitch T et al. Leuk Res. 2018 Jul 19. pii: S0145-2126(18)30160-7

CMS wants to flatten E/M payments, CMS proposed rule, CMS-1693-P

Lay health workers can assist with end-of-life care, Patel MI et al. JAMA Oncology. 2018 Jul 26. doi: 10.1001/jamaoncol.2018.2446.

New guidelines from the UK on chronic lymphocytic leukemia, Schuh AH et al. Br J Haematol. 2018 Jul 15. doi: 10.1111/bjh.15460

JAK1/2 inhibitors tied to increased B-cell lymphoma risk, Porpaczy E et al. Blood. 2018 Jun 14. doi: 10.1182/blood-2017-10-810739.

Must Reads in Thrombosis

Large cohort study demonstrates DOAC safety vs. warfarin , Vinogradova Y et al. BMJ 2018;362:k2505.

Poor adherence to DOAC therapy requires attention, Lakkireddy D et al. Heart Rhythm 2018, Abstract B-LBCT02-03.

Sepsis-related coagulopathy and in-hospital death risk, Lyons PG et al. Crit Care Med. 2018 May;46(5):73642.

New cancer drugs linked to fewer arrhythmias, Nickel A et al. annual meeting of the American College of Cardiology ACC 18, Abstract #900-06.

Increase kidney function monitoring if INR exceeds 4.0, Traquair H et al. biennial summit of the Thrombosis & Hemostasis Societies of North America 2018, Poster 79.